Biologic Excipients Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, India, Australia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Biologic Excipients Market size is projected to experience significant growth from 2019 to 2025.
 

Biologic excipients are inert pharmaceutical ingredients that are utilized in product formulations and find immense importance in the pharmaceutical industry. Each excipient serves a specific function and efficacy of final product depends upon the type of excipient chosen during manufacturing process.
 

Get more details on this report - Request Free Sample PDF
 

Increasing demand for generic drugs will positively impact biologic excipients market growth in the near future. Generic drugs are the exact copy of novel drugs that are available at lower prices in the market. These drugs provide same dosage, strength as well as quality of medication and make up for more than 80% prescriptions filled in the U.S. This scenario proves beneficial for industry growth as it increases the demand for biological excipients for manufacturing the generic drugs. Moreover, Asian countries with high disease prevalence project soaring demand for generics. For instance, Indian population majorly relies on the generic drugs as they are available at low prices and have showcased maximum efficacy in treating chronic diseases that has raised the demand for biologic excipients.
 

Growing adoption of multifunctionality excipients will stimulate biologic excipients market growth in the coming years. Multifunctionality excipients have several benefits associated with them that raises their demand in the manufacturing of drugs. Excipients play a vital role in drug formulation process as they have an importance in stabilizing the process, reducing the cost and improving the manufacturing efficiency. Above mentioned factors will spur the industry growth. However, stringent regulatory landscape for biologic excipients may restrain the industry growth to some extent.
 

Organic segment of biologic excipients market will witness substantial growth during the analysis timeframe. Considerable segmental growth can be associated with the specificity of organic excipients that aids drug delivery process. Organic biologic excipients enhance the bioavailability of the final drug. Furthermore, organic excipients cost less as compared to the inorganic excipients and also have commendable binding properties. Moreover, these excipients are majorly plant based and free from any side-effects that increases their preference thereby, fostering the segmental growth.
 

Binders segment held substantial market share in 2018 and significant segmental growth can be attributed to the increasing demand for binders in developing the pharmaceutical compounds.  Capsule binders are prominently utilized in the manufacturing of solid oral dosage forms for retaining the active pharmaceutical ingredient (API) together in a cohesive force. Binders utilized for wet granulation are hydrophilic and are highly soluble in water that further boosts their preference thereby, augmenting the segment growth.
 

Oral formulations segment accounted for significant revenue size in 2018. According to a survey, around 90% of the formulations available in the market are in the solid tablet form. Industry players have focused on integrating technology for facilitating the process of manufacturing oral formulations of improved quality. Furthermore, people usually prefer administering drugs through oral route since, it is convenient. Additionally, pharmacogenetics study suggests that efficacy of the oral formulations is considerably higher as compared to the topical formulations that positively influences the business growth.
 

U.S. biologic excipients industry is estimated to grow rapidly during the analysis period due to increasing prevalence of chronic disorders such as cancer and diabetes. According to National Cancer Institute, in 2018, over 1.7 million new cases of cancer were diagnosed and the number is still projected to increase in the near future. This scenario proves beneficial for the industry growth as it raises the demand for biological drugs. Furthermore, improving regulatory scenario will have a positive impact on the industry growth. Regulatory authorities are developing laws and regulations that has ensured availability of defect-free drugs in the market. Above mentioned factors propels the country growth.
 

Dupont De Nemours, Inc., Roquette Frères, Ashland, Meggle USA and Evonik Industries AG are some of the major market players involved in the global biologic excipients market. Key players are implementing strategic initiatives such as mergers and acquisitions as well as product launches for maintaining their market position. For instance, Meggle USA has developed Cellactose, a spray dried compound consisting of 75% of a lactose monohydrate having laudable binding power. Thus, introduction of such new products will foster company’s growth.
 

Biologic Excipients Market, By Product, 2014-2025 (USD Million)

• Organic
  • Oleochemicals
  • Carbohydrates
  • Cellulose
  • Starch
  • Petrochemicals
  • Proteins
  • Others
• Inorganic
  • Calcium Phosphate
  • Metal Oxides
  • Calcium Carbonate
  • Others
• Others

Biologic Excipients Market, By Functionality, 2014-2025 (USD Million)

• Fillers & diluents
• Suspending & viscosity agents
• Coating agents
• Binders
• Flavoring agents & sweeteners
• Disintegrants
• Emulsifying agents
• Others

Biologic Excipients Market, By Formulation Type, 2014-2025 (USD Million)

• Oral formulation
• Topical formulation
• Parenteral formulation
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa
  • South Africa
  • Saudi Arabia

Company Profiles:

• Dupont De Nemours, Inc.
• Roquette Frères
• Ashland Global Holdings Inc.
• Evonik Industries AG
• BASF SE
• MEGGLE USA
• Kerry Group PLC
• Croda International
• Colorcon Inc.

What Information does this report contain?